Angiodynamics Stock Performance
| ANGO Stock | USD 11.26 0.29 2.64% |
The firm shows a Beta (market volatility) of 1.17, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AngioDynamics will likely underperform. At this point, AngioDynamics has a negative expected return of -0.0818%. Please make sure to confirm AngioDynamics' total risk alpha, as well as the relationship between the kurtosis and day typical price , to decide if AngioDynamics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days AngioDynamics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, AngioDynamics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (0.54) | Five Day Return (4.77) | Year To Date Return (13.49) | Ten Year Return 4.68 | All Time Return (12.24) |
1 | Disposition of 3673 shares by James Clemmer of AngioDynamics at 8.99 subject to Rule 16b-3 | 12/10/2025 |
2 | Acquisition by Lawrence Weiss of 30900 shares of AngioDynamics subject to Rule 16b-3 | 12/24/2025 |
3 | AngioDynamics Q1 2026 Earnings Transcript | 01/06/2026 |
4 | AngioDynamics, Inc. Q2 2026 Earnings Call Transcript | 01/07/2026 |
5 | Acquisition by Licitra Karen A of 20541 shares of AngioDynamics subject to Rule 16b-3 | 01/08/2026 |
6 | Assessing AngioDynamics Valuation After Raised Guidance And Med Tech Momentum | 01/09/2026 |
7 | Down 25.0 percent in 4 Weeks, Heres Why You Should You Buy the Dip in AngioDynamics | 01/12/2026 |
8 | Global Tumor Ablation Market Set to Reach USD 1.4 Billion by 2029 MarketsandMarkets | 01/15/2026 |
9 | Heres Why AngioDynamics Is a Great Buy the Bottom Stock Now | 01/30/2026 |
10 | AngioDynamics and The PERT Consortium Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care | 02/05/2026 |
11 | AngioDynamics, PERT Consortium launch pulmonary embolism research fund | 02/06/2026 |
| Begin Period Cash Flow | 76.1 M | |
| Total Cashflows From Investing Activities | -10.2 M |
AngioDynamics | Build AI portfolio with AngioDynamics Stock |
AngioDynamics Relative Risk vs. Return Landscape
If you would invest 1,190 in AngioDynamics on November 19, 2025 and sell it today you would lose (93.00) from holding AngioDynamics or give up 7.82% of portfolio value over 90 days. AngioDynamics is currently does not generate positive expected returns and assumes 3.2592% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than AngioDynamics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AngioDynamics Target Price Odds to finish over Current Price
The tendency of AngioDynamics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 11.26 | 90 days | 11.26 | about 67.89 |
Based on a normal probability distribution, the odds of AngioDynamics to move above the current price in 90 days from now is about 67.89 (This AngioDynamics probability density function shows the probability of AngioDynamics Stock to fall within a particular range of prices over 90 days) .
AngioDynamics Price Density |
| Price |
Predictive Modules for AngioDynamics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AngioDynamics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.AngioDynamics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AngioDynamics is not an exception. The market had few large corrections towards the AngioDynamics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AngioDynamics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AngioDynamics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.2 | |
β | Beta against Dow Jones | 1.17 | |
σ | Overall volatility | 1.27 | |
Ir | Information ratio | -0.06 |
AngioDynamics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AngioDynamics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AngioDynamics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AngioDynamics generated a negative expected return over the last 90 days | |
| AngioDynamics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 292.5 M. Net Loss for the year was (33.99 M) with profit before overhead, payroll, taxes, and interest of 167.72 M. | |
| AngioDynamics currently holds about 24.56 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31. | |
| AngioDynamics has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from massdevice.com: AngioDynamics, PERT Consortium launch pulmonary embolism research fund |
AngioDynamics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AngioDynamics Stock often depends not only on the future outlook of the current and potential AngioDynamics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AngioDynamics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41 M | |
| Cash And Short Term Investments | 55.9 M |
AngioDynamics Fundamentals Growth
AngioDynamics Stock prices reflect investors' perceptions of the future prospects and financial health of AngioDynamics, and AngioDynamics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AngioDynamics Stock performance.
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.046 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 412.39 M | ||||
| Shares Outstanding | 41.22 M | ||||
| Price To Earning | 7.90 X | ||||
| Price To Book | 2.57 X | ||||
| Price To Sales | 1.47 X | ||||
| Revenue | 292.5 M | ||||
| Gross Profit | 167.72 M | ||||
| EBITDA | 1.74 M | ||||
| Net Income | (33.99 M) | ||||
| Cash And Equivalents | 24.56 M | ||||
| Cash Per Share | 0.31 X | ||||
| Total Debt | 3.95 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 2.28 X | ||||
| Book Value Per Share | 4.24 X | ||||
| Cash Flow From Operations | (10.13 M) | ||||
| Earnings Per Share | (0.67) X | ||||
| Market Capitalization | 452.15 M | ||||
| Total Asset | 280.14 M | ||||
| Retained Earnings | (429.2 M) | ||||
| Working Capital | 92.13 M | ||||
| Current Asset | 146.25 M | ||||
| Current Liabilities | 66.73 M | ||||
About AngioDynamics Performance
By examining AngioDynamics' fundamental ratios, stakeholders can obtain critical insights into AngioDynamics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that AngioDynamics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 193.09 | 163.78 | |
| Return On Tangible Assets | (0.19) | (0.18) | |
| Return On Capital Employed | (0.23) | (0.21) | |
| Return On Assets | (0.14) | (0.13) | |
| Return On Equity | (0.17) | (0.18) |
Things to note about AngioDynamics performance evaluation
Checking the ongoing alerts about AngioDynamics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AngioDynamics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AngioDynamics generated a negative expected return over the last 90 days | |
| AngioDynamics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 292.5 M. Net Loss for the year was (33.99 M) with profit before overhead, payroll, taxes, and interest of 167.72 M. | |
| AngioDynamics currently holds about 24.56 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31. | |
| AngioDynamics has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from massdevice.com: AngioDynamics, PERT Consortium launch pulmonary embolism research fund |
- Analyzing AngioDynamics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AngioDynamics' stock is overvalued or undervalued compared to its peers.
- Examining AngioDynamics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AngioDynamics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of AngioDynamics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AngioDynamics' stock. These opinions can provide insight into AngioDynamics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Will Health Care Equipment & Supplies sector continue expanding? Could AngioDynamics diversify its offerings? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AngioDynamics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.67) | Revenue Per Share | Quarterly Revenue Growth 0.09 | Return On Assets | Return On Equity |
Investors evaluate AngioDynamics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating AngioDynamics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause AngioDynamics' market price to deviate significantly from intrinsic value.
Understanding that AngioDynamics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AngioDynamics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, AngioDynamics' market price signifies the transaction level at which participants voluntarily complete trades.